Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • AYUSH
    • Create separate drug...

    Create separate drug controller for AYUSH medicines: Parliamentary Committee

    Written by Ruby Khatun Khatun Published On 2018-04-08T10:30:40+05:30  |  Updated On 8 April 2018 10:30 AM IST
    Create separate drug controller for AYUSH medicines: Parliamentary Committee

    New Delhi: A parliamentary committee sought the creation of a separate drug controller for AYUSH medicines and drugs in a time-bound manner to ensure they are on a par with international standards.


    The committee, which pointed out that market of Indian herbal drugs was declining worldwide, lamented the delay by the AYUSH ministry in fulfilling the assurance given on the issues of separate drug controller and legislation for education and practice of AYUSH systems of medicine.


    According to the report submitted in the Lok Sabha today, the ministry had moved a proposal for setting up a separate drug controller for AYUSH medicines and it was put up for Cabinet approval.


    However, upon a directive from PMO, the ministry decided to set up a vertical structure of AYUSH in the existing Central Drugs Standard Control Organization (CDSCO).


    "Putting AYUSH drugs under the same structure of CDSCO as allopathic medicines is gross injustice towards AYUSH medicines and will not lead to the fulfillment of the assurance which was given," the report stated.


    Since an inordinate length of time has been taken by the ministry without fulfilling the assurance, the committee directed the ministry to fulfill it in a time-bound manner and, meanwhile, also furnish a part implementation report detailing steps taken by it to ensure quality, safety, efficacy, and standard of AYUSH drugs in the country.


    The committee pointed out that two more assurances pertaining to the legislation for education and practice of AYUSH systems of medicine have been kept pending by the ministry for more than two years.


    The committee expressed concern to note that there is no licensing authority for AYUSH medicines despite the fact that these are eternal medicinal practices.


    It observed that absence of licensing authority for AYUSH medicines is the main reason for these medicines not getting the recognition they deserve in the country and abroad.


    It also pointed out that there are no specific pharmacists for selling AYUSH medicines and no course has been prescribed for them as a result of which many countries have banned AYUSH medicines in their markets.


    The committee also asked the Ministry of AYUSH to streamline the mechanism for implementation of eight assurances given by the government which are still pending.

    AyushAyush medicinesAyush MinistryCDSCOCentral Drugs Standard Control OrganizationcreationDrug ControllerIndian herbal drugsinternational standardsmedicinesMinistry of AyushParliamentary Committeeseeksseparate
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok